Warburg Pincus will acquire a “significant” minority stake in Sebia, according to a news release.
Sebia, founded in 1967 and with its U.S. headquarters in Norcross, Georgia, is a global provider of specialty diagnostics. The company specializes in vitro diagnostics, providing instruments and reagents for screening and monitoring diseases in oncology, diabetes, hemoglobinopathies,